Table 4 Rhythm control intervention during the follow-up period after LAA closure
Age (range) | Cardiac rhythm before LAA closure | History of thromboembolic event | History of AF ablation | CHA2DS2-VASc score | Procedure of interventional cardiology | Thomboembolic event after cardioversion or an ablation procedure | Antithrombotic treatment before the procedure | Antithrombotic treatment after the procedure |
|---|---|---|---|---|---|---|---|---|
70′s–80′s | Sinus rhythm | No | No | 2 | Electrical cardioversion | No | VKA | VKA |
80′s–90′s | Atrial fibrillation | Yes | No | 5 | Electrical cardioversion | No | Short term anticoagulation + Antiplatelet therapy | Low Molecular Weight Heparine + Antiplatelet therapy |
80′s–90′s | Sinus rhythm | No | No | 2 | Overdrive pacing | No | Antiplatelet therapy | Antiplatelet therapy |
70′s–80′s | Sinus rhythm | No | No | 4 | Overdrive pacing | No | None | None |
70′s–80′s | Sinus rhythm | No | Yes | 2 | Atrial fibrillation ablation (CP with LAAC, Pulmonary vein isolation) | No | None | DOAC |
60′s–70′s | Sinus rhythm | Yes | Yes | 5 | Left Atrial flutter ablation (Pulmonary vein isolation) | No | Antiplatelet therapy | Antiplatelet therapy |
60′s–70′s | Atrial fibrillation | Yes | No | 2 | Right common flutter ablation (cavotricuspid isthmus ablation) | No | Antiplatelet therapy | Antiplatelet therapy |
70′s–80′s | Sinus rhythm | No | No | 4 | 2 ablation procedures: 1) CP with LAAC (cavotricuspid isthmus ablation); 2) Subsequent ablation: (Pulmonary vein isolation) | No | None VKA | Antiplatelet therapy None |
50′s–60′s | Atrial fibrillation | Yes | No | 3 | Atrial fibrillation ablation (pulmonary vein isolation isolation) and right common flutter ablation (cavotricuspid isthmus ablation) | No | DOAC + Antiplatelet therapy | DOAC + Antiplatelet therapy |
60′s–70′s | Sinus rhythm | Yes | Yes | 4 | Atrial fibrillation ablation (CP with LAAC, Pulmonary vein isolation) | No | DOAC | DOAC |
60′s–70′s | Sinus rhythm | No | No | 1 | Atrial fibrillation ablation (CP with LAAC, Pulmonary vein isolation) | No | Antiplatelet therapy | Low Molecular Weight Heparine + Antiplatelet therapy |
60′s–70′s | Sinus rhythm | No | No | 2 | Atrial fibrillation ablation (CP with LAAC, Pulmonary vein isolation) | No | Antiplatelet therapy + VKA | Antiplatelet therapy + VKA |
60′s–70′s | Sinus rhythm | No | Yes | 2 | Atrial fibrillation ablation (CP with LAAC, Pulmonary vein isolation) | No | None | Low Molecular Weight Heparine + Antiplatelet therapy |